A
AFT Pharmaceuticals Ltd
NZX:AFT
AFT Pharmaceuticals Ltd
NZX:AFT
Price:
2.9 NZD
-2.36%
Market Closed
Updated:
May 7, 2024
AFT Pharmaceuticals Ltd
Net Income (Common)
|
AFT Pharmaceuticals Ltd
Net Income (Common) Peer Comparison
Comparables:
BLT
CBD
RUA
G
GFI
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
Net Income (Common)
NZ$11m
|
CAGR 3-Years
55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
BLIS Technologies Ltd
NZX:BLT
|
Net Income (Common)
-NZ$1.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Cannasouth Ltd
NZX:CBD
|
Net Income (Common)
-NZ$8.8m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-105%
|
CAGR 10-Years
N/A
|
|
|
Rua Bioscience Ltd
NZX:RUA
|
Net Income (Common)
-NZ$6m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
G
|
Greenfern Industries Ltd
NZX:GFI
|
Net Income (Common)
-NZ$2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AFT Pharmaceuticals Ltd's Net Income (Common)?
Net Income (Common)
11m
NZD
11m
NZD
Based on the financial report for Sep 30, 2023, AFT Pharmaceuticals Ltd's Net Income (Common) amounts to 11m NZD.
What is AFT Pharmaceuticals Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
55%
55%
Over the last year, the Net Income (Common) growth was -35%. The average annual Net Income (Common) growth rates for AFT Pharmaceuticals Ltd have been 55% over the past three years .
You don't have any saved screeners yet
